0 Dr. Neelam V. Shirsat

Dear Colleagues,

Warm greetings, I am deeply honoured to take over as the President of ISNO for the year 2023-24. Thanks to the efforts of Dr. Rakesh Jalali and several other members, ISNO has established itself as the association that has brought together the neurooncology community in India in its scientific pursuit.

The last decade has seen genomic analysis bringing about phenomenal improvement in the diagnosis of brain tumors. Molecular diagnosis though appears to be daunting at first, has not only led to accurate diagnosis but also identified several subtypes that significantly improved risk stratification. ISNO has been at the forefront, in bringing about national guidelines for the management of several brain tumor types.

The next decade is expected to see an emergence of novel targeted therapies that would be not only risk-adapted but would hopefully also result in significant improvement in the survival of brain tumor patients. Cross-country clinical trials using novel strategies are the need of the hour in which ISNO could play an important role. It is all the more important now that ISNO membership reaches across the length and breadth of the country. I sincerely hope that active participation and collaboration by ISNO members helps ISNO achieve its ultimate goal of delivering quality care to all brain tumor patients in India.

Best regards

Dr. Neelam V. Shirsat
President, ISNO